Drug Trial Radar · NCT06376045
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma
Last checked: Nov 19, 2026Latest source record: Aug 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
317
Actual
Start
May 24, 2024
Primary completion
May 14, 2026
Study completion Jun 23, 2026
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Apr 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.
Conditions
- Asthma
Interventions
RocatinlimabDrug
Rocatinlimab will be administered by SC injection.
PlaceboDrug
Placebo will be administered by SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Composite Endpoint for Exacerbations (CompEx) Events During the Blinded Treatment PeriodTime frame: Up to Week 48
Locations
154 sites in 19 countries. Site status is shown where the registry gives one.
Kern Research Inc
Bakersfield, California
Orso Health Inc
La Jolla, California
Imax Clinical Trials
La Palma, California
Antelope Valley Clinical Trials
Lancaster, California
Downtown Los Angeles Research Center, Inc
Los Angeles, California
NewportNativeMD, Inc
Newport Beach, California
University of California Irvine
Orange, California
Apex Clinical Research
San Diego, California
Allergy and Asthma Clinical Research
Walnut Creek, California
Allianz Research Institute Westminster
Westminster, California
St Francis Medical Institute
Clearwater, Florida
BioMed Research Institute
Miami, Florida
Bright Research Center LLC
Miami, Florida
Infinity Life Research Group
Tamarac, Florida
Clinical Research Trials of Florida Inc
Tampa, Florida
AllerVie Clinical Research- Columbus
Columbus, Georgia
Treasure Valley Medical Research
Boise, Idaho
Sneeze, Wheeze, and Itch Associates, LLC
Normal, Illinois
Family Allergy and Asthma Research Institute
Louisville, Kentucky
Chesapeake Clinical Research Inc
White Marsh, Maryland
Henry Ford Health System
Detroit, Michigan
Respiratory Medicine Research Institute of Michigan, plc
Ypsilanti, Michigan
Midwest Chest Consultants, PC
Saint Charles, Missouri
Montana Medical Research
Missoula, Montana
Somnos Clinical Research
Lincoln, Nebraska
Hudson County Clinical Trials Research Center
Union City, New Jersey
Northwell Health
New Hyde Park, New York
Duke Asthma Research Center
Durham, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina
Bernstein Clinical Research Center LLC
Cincinnati, Ohio
OK Clinical Research
Edmond, Oklahoma
Velocity Clinical Research Medford
Medford, Oregon
Clinical Research Associates of Central Pennsylvania
DuBois, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
The Allergy Asthma and Sinus Center
Knoxville, Tennessee
Amarillo Medical Specialists
Amarillo, Texas
TTS Research
Boerne, Texas
TEN20 Clinical Research
Carrollton, Texas
Alina Clinical Trials, LLC
Dallas, Texas
Southwest Family Medicine Associates
Dallas, Texas
Showing 40 of 154 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.